首站-论文投稿智能助手
典型文献
CYP2C19 Genotyping Plus Therapeutic Drug Monitoring Dependent Voriconazole Treatment for Invasive Pulmonary Aspergillosis in a Patient with Liver Failure
文献摘要:
Invasive pulmonary aspergillosis (IPA) is a lethal infectious disease with high mortality in patients with liver failure. Early recognition of the risk factors prompting earlier diagnosis and treatment may improve the outcomes. Voriconazole is recommended as the first-line drug for IPA, but hepatotoxicity limits its use in the context of liver diseases. We report a case of a 63-year-old female who was admitted to the Third Affiliated Hospital of Hebei Medical University due to IPA after glucocorticoid therapy for liver failure. The polymorphism of cytochrome P450 (CYP) isoenzymes showed CYP2C19*1/*2 genotype associated with intermediate metabolism of voriconazole. However, the patient developed side effects such as skin rash, vomiting, hyperbilirubinemia, and alteration of consciousness, even if she received half of the recommended dosage for voriconazole. Therapeutic drug monitoring (TDM) was applied to guide the dosage adjustment of voriconazole in this patient, and consequently, the patient presented a favorable outcome. In conclusion, genotyping screening plus TDM dependent individualized treatment of voriconazole may improve the survival of liver failure patient with IPA.
文献关键词:
Invasive pulmonary aspergillosis;Liver failure;Therapeutic drug monitoring;Voriconazole
作者姓名:
Shen Chuan;Zhao Qian;Li Ziyue;Wang Wei;Zhao Yalin;Kong Lingya;Xie Jing;Zhao Caiyan
作者机构:
Department of Infectious Disease, Third Affiliated Hospital of Hebei Medical University, Shijiazhuang 050051, China;Clinical Research Center for Infectious Disease of Hebei Province, Shijiazhuang 050051, China;Office of Quality Management and Control in Healthcare, Third Affiliated Hospital of Hebei Medical University, Shijiazhuang 050051, China
引用格式:
[1]Shen Chuan;Zhao Qian;Li Ziyue;Wang Wei;Zhao Yalin;Kong Lingya;Xie Jing;Zhao Caiyan-.CYP2C19 Genotyping Plus Therapeutic Drug Monitoring Dependent Voriconazole Treatment for Invasive Pulmonary Aspergillosis in a Patient with Liver Failure)[J].感染性疾病和免疫(英文),2022(02):125-128
A类:
Voriconazole,Aspergillosis,voriconazole
B类:
CYP2C19,Genotyping,Plus,Therapeutic,Drug,Monitoring,Dependent,Treatment,Invasive,Pulmonary,Patient,Liver,Failure,pulmonary,aspergillosis,IPA,lethal,infectious,high,mortality,patients,liver,failure,Early,recognition,risk,factors,prompting,earlier,diagnosis,treatment,may,improve,outcomes,recommended,first,line,drug,but,hepatotoxicity,limits,use,context,diseases,We,report,case,year,old,female,who,was,admitted,Third,Affiliated,Hospital,Hebei,Medical,University,due,after,glucocorticoid,therapy,polymorphism,cytochrome,P450,isoenzymes,showed,genotype,associated,intermediate,metabolism,However,developed,side,effects,such,skin,rash,vomiting,hyperbilirubinemia,alteration,consciousness,even,if,she,received,half,dosage,monitoring,TDM,applied,guide,adjustment,this,consequently,presented,favorable,conclusion,genotyping,screening,plus,dependent,individualized,survival
AB值:
0.603137
相似文献
Existing tests vs. novel non-invasive assays for detection of invasive aspergillosis in patients with respiratory diseases
Xiao Wei;Du Longyi;Cai Linli;Miao Tiwei;Mao Bing;Wen Fuqiang;Gibson Peter Gerard;Gong Deying;Zeng Yan;Kang Mei;Du Xinmiao;Qu Junyan;Wang Yan;Liu Xuemei;Feng Ruizhi;Fu Juanjuan-Respiratory Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China;Divison of Pulmonary Diseases, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, Sichuan 610093, China;West China School of Medicine, Sichuan University, Chengdu, Sichuan 610041, China;Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China;Priority Research Centre for Healthy Lungs, The University of Newcastle, Newcastle, NSW 2305, Australia;Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, Newcastle, NSW 2305, Australia;Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW 2305, Australia;Laboratory of Anesthesia and Critical Care Medicine, Translational Neuroscience Center, West China Hospital of Sichuan University, Chengdu, Sichuan 610093, China;Department of Pneumology, Pidu District of Traditional Chinese Medicine, The Third Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 611730, China;Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China;Center of Infectious Disease, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China;Research Core Facility, West China Hospital of Sichuan University, Chengdu, Sichuan 610093, China
Analysis of risk factors associated with endoscopic retrograde cholangiopancreatography for patients with liver cirrhosis: a multicenter, retrospective, clinical study
Li Jielin;Hu Jiexuan;Li Peng;Wu Yongdong;Wang Yongjun;Ji Ming;Hua Haiyang;Ran Wenbin;Pan Yanglin;Zhang Shutian-Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing 100050, China;Department of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China;Department of Gastroenterology, Cheng De Central Hospital, Chengde, Hebei 067000, China;Department of Gastroenterology, The Third People’s Hospital of Chengdu, Chengdu, Sichuan 610031, China;Xijing Hospital of Digestive Diseases, Air Force Medical University of People’s Liberation Army, Xi’an, Shaanxi 710032, China
Factors Predicting Progression to Severe COVID-19:A Competing Risk Survival Analysis of 1753 Patients in Community Isolation in Wuhan,China
Simiao Chen;Hui Sun;Mei Heng;Xunliang Tong;Pascal Geldsetzer;Zhuoran Wang;Peixin Wu;Juntao Yang;Yu Hu;Chen Wang;Till B?rnighausen-Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing 100730,China;Heidelberg Institute of Global Health(HIGH),Faculty of Medicine and University Hospital,Heidelberg University,Heidelberg 69120,Germany;Institute of Hematology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Department of Pulmonary and Critical Care Medicine,Beijing Hospital,Beijing 100730,China;National Center of Gerontology,Institute of Geriatric Medicine,Beijing 100730,China;Division of Primary Care and Population Health,Department of Medicine,Stanford University,Stanford,CA 94305,USA;Peking Union Medical College Hospital,Beijing 100730,China;State Key Laboratory of Medical Molecular Biology,Institute of Basic Medical Sciences,Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing 100730,China;National Clinical Research Center for Respiratory Diseases,Beijing 100029,China;Department of Pulmonary and Critical Care Medicine,Center of Respiratory Medicine,China-Japan Friendship Hospital,Beijing 100029,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。